Ardelyx Inc. ARDX
$5.75
▼ -1.73% 24H
About
Ardelyx Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing first-in-class medicines to address unmet medical needs in gastrointestinal and cardio-renal diseases. The company employs an innovative platform that identifies new biological mechanisms and pathways, enabling the creat…
SectorHealthcare
ExchangeNASDAQ
IndustryBiotechnology
CountryUnited States
Employees395
TickerARDX
Statistics
Market Cap$1.42B
Revenue (TTM)$407.3M
Net Income-$61.6M
Net Margin-15.1%
EPS$-0.26
P/E-22.38
P/S3.24
P/B9.32
EV/EBITDA-40.51
ROE-39.5%
Dividend Yield—
Price$5.75
Data: Twelve Data · Revenue = mcap / P/S